Showing results (191-200 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 27, 2023
Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm TypeKoji Matsuo, Rachel S Mandelbaum, Andrew Vallejo, et al.
JAMA Oncology|October 6, 2022
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and MisinterpretationsFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
JAMA Oncology|October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration StatusJithma P Abeykoon, Karen L Rech, Jason R Young, et al.
JAMA Oncology|September 15, 2022
Short-term Outcomes of Laparoscopy-Assisted vs Open Surgery for Patients With Low Rectal Cancer: The LASRE Randomized Clinical TrialWei-Zhong Jiang, Jian-Min Xu, Jia-Di Xing, et al.
JAMA Oncology|October 13, 2022
Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysisAbdulhadi Jfri, Rachel Meltzer, Arash Mostaghimi, et al.
JAMA Oncology|September 1, 2022
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity SyndromeOmar H Butt, Alice Y Zhou, Paolo F Caimi, et al.
JAMA Oncology|August 25, 2022
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer DiagnosisAnna Marklund, Tobias Lekberg, Elham Hedayati, et al.
JAMA Oncology|December 7, 2023
Population Attributable Risk of Advanced-Stage Breast Cancer by Race and EthnicityKarla Kerlikowske, Shuai Chen, Michael C S Bissell, et al.
JAMA Oncology|December 21, 2023
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical TrialYoshimasa Shiraishi, Junji Kishimoto, Shunichi Sugawara, et al.
JAMA Oncology|March 28, 2024
Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung CancerKentaro Ito, Yuta Suzuki, Tadashi Sakaguchi, et al.
Pageof 161